Suchergebnisse - "Fajgenbaum, David C."

PubPharm (6)

1

Case 16-2022 : A Man with Fevers, Night Sweats, and a Mediastinal Mass. Reply

enthalten in: The New England journal of medicine | 2022

von Fajgenbaum, D.

CommentOn: N Engl J Med. 2022 Aug 25;387(8):762-763. - PMID 36001726

2

Anti-type I interferon antibodies as a cause of severe COVID-19

enthalten in: Faculty reviews | 2022

von Fajgenbaum, D. | Hayday, A. | Rogers, A. | +3

CommentOn: Science. 2020 Oct 23;370(6515):. - PMID 32972996

3

Cytokine Storm. Reply

enthalten in: The New England journal of medicine | 2021

von Fajgenbaum, D. | June, C.

CommentOn: N Engl J Med. 2021 Apr 22;384(16):e59. - PMID 33882214

4

Comment on : HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease: reply

enthalten in: Rheumatology (Oxford, England) | 2021

von Kawano, M. | Sato, Y. | Fajgenbaum, D.

CommentOn: Rheumatology (Oxford). 2021 Jan 5;60(1):e3-e4. - PMID 32772106

5

Commentary on A Case of Rapid Deterioration with Marked Hypergammaglobulinemia

enthalten in: Clinical chemistry | 2020

von Fajgenbaum, D. | Phillips, A.

CommentOn: Clin Chem. 2020 Nov 1;66(11):1373-1378. - PMID 33141911

6

The collaborative network approach : a new framework to accelerate Castleman's disease and other rare disease research

enthalten in: The Lancet. Haematology | 2016

von Fajgenbaum, D. | Ruth, J. | Kelleher, D. | +1

CommentOn: Lancet Haematol. 2016 Apr;3(4):e163-75. - PMID 27063975

1
[1]